Olpasiran Expanded Access Program

Amgen

Status

Treatments: Drug: Olpasiran

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT07079267

Olpasiran Expanded Access

Details and patient eligibility

About

Expanded access requests for Olpasiran may be considered for adult participants with elevated Lp(a) and atherosclerotic cardiovascular disease (ASCVD). To request access, use Responsible Party contact information provided in this record.

Sex

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria